Crescita Therapeutics Inc. (TSX:CTX)

Crescita Therapeutics Revenue

Crescita Therapeutics had revenue of 5.64M CAD in the quarter ending March 31, 2026, with 59.37% growth. This brings the company's revenue in the last twelve months to 23.22M, up 28.13% year-over-year. In the year 2025, Crescita Therapeutics had annual revenue of 21.12M with 7.85% growth.

• Revenue (ttm): 23.22M
• Revenue Growth: +28.13%
• P/S Ratio: 0.61
• Revenue / Employee: 357.20K
• Employees: 65
• Market Cap: 14.15M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	21.12M	1.54M	7.85%
Dec 31, 2024	19.58M	2.06M	11.75%
Dec 31, 2023	17.52M	-6.00M	-25.52%
Dec 31, 2022	23.53M	6.76M	40.29%
Dec 31, 2021	16.77M	1.13M	7.22%
Dec 31, 2020	15.64M	-6.70M	-29.98%
Dec 31, 2019	22.34M	5.71M	34.33%
Dec 31, 2018	16.63M	4.61M	38.41%
Dec 31, 2017	12.01M	8.51M	242.87%
Dec 31, 2016	3.50M	3.28M	1,436.84%
Dec 31, 2015	228.00K	-602.00K	-72.53%
Dec 31, 2014	830.00K	-	-

Data Source: Fiscal.ai Last updated: May 11, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 22, 2026

Data Sources Report a data error